Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Some patients experience mild discomfort at the injection site, temporary flushing or a metallic taste during the infusion
281 As approved by the FDA in 2018 for the treatment of ATTR-PN, Inotersen requires regular safety monitoring for potential adverse events, particularly thrombocytopenia and glomerulonephritis
A density functional study on the effect of the trans axial ligand of cobalamin on the homolytic cleavage of the Co C bond
Protective effects of intra-articular formulated liraglutide in osteoarthritis: Preclinical studies
Focus on trouble areas
US$ 21.88
US$ 21.98
US$ 27.31
US$ 28.49
